Using the isolated perfused rat heart with transient (10-minute) regional ischemia induced by coronary artery ligation, we have shown that PBN (N-tert-butyl-a-phenylnitrone), an organic spin trap agent designed specifically to form "stable" adducts with free radicals in electron spin resonance studies, can dramatically reduce the vulnerability of the myocardium to reperfusion-induced ventricular fibrillation. Studied in the concentration range of 5-1,000 fiM/L, PBN added to the perfusate 5 minutes prior to ischemia exerted a dose-dependent protective effect. At the optimum concentration of 30 /txM/L PBN reduced the incidence of ventricular fibrillation to 50% (6 of 12) from its control value of 100% (12 of 12). The antiarrhythmic effect was achieved without any substantial effect on coronary flow or heart rate. Investigating whether this was a direct antiarrhythmic effect, operating during reperfusion, or an indirect effect arising from the action of PBN on the heart during ischemia, PBN (30 /uM/L) was added to the perfusion fluid 2 minutes before reperfusion. In the control group, 100% of the hearts fibrillated whereas only 50% fibrillated in the PBN group. Additional studies were designed to ascertain whether the drug caused an absolute reduction in vulnerability to reperfusion-induced arrhythmias (irrespective of the duration of ischemia) or whether it only shifted the ischemic timereperfusion vulnerability curve to the right (i.e., delayed the onset of vulnerability). Thus, studies were undertaken to define the relation between the duration of ischemia and the incidence of reperfusion-induced arrhythmias in control hearts and hearts treated with PBN. Hearts (12 for each group) were subjected to 5, 10, 20, 30, or 40 minutes ischemia; PBN (30 /uM/L) was added to the perfusate either 5 minutes before ischemia or 2 minutes before reperfusion. The results were compared to PBNfree control hearts. In each instance, a bell-shaped time-response profile was obtained. In the PBNfree controls, this gave a maximal vulnerability to reperfusion-induced arrhythmias after 10 minutes of ischemia; in the PBN-treated hearts, this curve was shifted to the right and slightly downwards. These results indicate that the primary action of PBN is to exert a delaying effect, which essentially extends the duration of ischemia that can be tolerated before the heart becomes highly vulnerable to reperfusion-induced arrhythmias. However, this effect is achieved during the reperfusion period and not during the preceding period of ischemia. The precise mechanism by which this free radical spin trapping agent achieves this unusual protective effect remains to be resolved. (Circulation Research
T he recognition of reperfusion-induced arrhythmias as a frequent, clinically encountered phenomenon has stimulated considerable interest in the mechanisms underlying their genesis and pharmacological control. 1 ' 2 Reperfusion-induced arrhythmias may occur as the consequence of the spontaneous relief of coronary spasm, 3 regional reflow with spontaneous or induced thrombolysis during evolving myocardial infarction, 4 or whole heart reflow after ischemic arrest during cardiac surgery. 56 A variety of trigger mechanisms have been proposed to explain the genesis of ischemia and reperfusion-induced arrhythmias, including the stimulation of a and /3 receptors, 7 " 9 the elevation of cAMP, 10 the formation of lysophos-phatides," and disturbance of ionic homeostasis, particularly that of calcium and potassium. 1213 Recent studies 214 " 16 have introduced the concept that reactive oxygen intermediates, such as the superoxide (O 2 "~) and hydroxyl radical (OH'), which are formed during reperfusion or reoxygenation of ischemic or hypoxic tissue, may be responsible for the induction of electrophysiological disturbances that lead to the development of ventricular fibrillation. It is becoming well established that these and other free radicals derived from a variety of sources such as xanthine oxidase, 17 leukocytes, 18 arachidonic acid, 19 catecholamines, 20 or mitochondria 21 can play a major role in the pathophysiology of various aspects of ischemia-and reperfusion-induced injury. 22 In support of the hypothesis of an association between reperfusion-induced arrhythmias and free radical production, Manning et al and Bernier et al 1415 have shown in the rat, both in vivo and in vitro, that a variety of inhibitors of free radical production (e.g., allopurinol) or scavengers of free radicals (e.g., superoxide dismutase, catalase, mannitol, glutathione, and methionine) are able to reduce or abolish ventricular fibrillation associated with reperfusion following a brief (5-15 minutes) period of ischemia. With in vitro studies, Woodward and Zakaria 16 and Bernier et al 15 have shown that free radical generating systems such as FeCl 3 plus ADP and hypoxanthine plus xanthine oxidase are able to dramatically increase the vulnerability of the heart to reperfusion-induced arrhythmias.
At present, the association between free radicals and reperfusion-induced arrhythmias is circumstantial in that the complexities inherent in their measurement makes it difficult to demonstrate their production at the time of arrhythmia induction. Even with electron spin resonance techniques, the transient existence of the free radicals often demands that various organic spin trapping agents be used to create stable adducts, which are capable of being detected and identified. As a first step in this direction, we have been assessing the feasibility of perfusing hearts with one such spin trapping agent, PBN (N-tert-butyl-a-phenylnitrone). This article reports how this agent, which is specifically designed to trap free radicals, exerts an antiarrhythmic effect in the isolated rat heart subjected to regional ischemia and reperfusion.
Materials and Methods Perfusion Technique and Perfusion Medium
Male Wistar rats (220-280 g body weight, Bantin and Kingman) were used for all studies. Animals were anesthetized with diethyl ether, and heparin (200 U) was injected intravenously. After 30 seconds, the hearts were excised and placed in cold (4° C) perfusion medium until contraction had ceased (approximately 30 seconds). Each heart was then cannulated via the aorta and perfused by the Langendorff method 23 at a constant perfusion pressure equivalent to 100 cm water. Under these conditions, control coronary flow at the onset of each experiment was approximately 15 ml/min/g wet wt. Bicarbonate buffer, 24 modified to contain 11.1 mM glucose/L and 4.3 mM potassium/L, was the perfusion fluid, and this was gassed with 95% oxygen and 5% carbon dioxide (pH 7.4 at 37° C). During preparation of the perfusion fluid, precautions were taken to prevent the precipitation of calcium, 25 and prior to use all solutions were filtered through a 5 /xm porosity filter to remove any paniculate contaminants.
Induction of Ischemia and Reperfusion
At the onset of each experiment, a suture was placed around the left anterior descending coronary artery at a point close to its origin. Both ends of the ligature were then passed through a small plastic tube. Regional ischemia could be induced at any time by pulling the suture while pressing the tube against the surface of the myocardium; the ischemia could then be maintained for any desired period by clamping the tubing and the sutures. Reperfusion could be initiated by unclamping and removing the plastic tube. In preliminary control experiments, the successful induction of ischemia and the adequacy of reperfusion were confirmed by perfusing the hearts with disulphine blue dye.
Experimental Time Course
Three basic protocols were employed.
PROTOCOL FOR EARLY ADMINISTRATION, PBN DOSE-RE-SPONSE STUDIES. Hearts (n = 12 in each group) were perfused for 2 successive 5-minute preischemic control periods. During the first 5 minutes, standard perfusion medium was used and control drug-free measurements of the electrocardiogram, heart rate, and coronary flow were recorded. During the second 5-minute period of preischemic perfusion, the composition of the perfusion fluid was changed by switching to a second perfusion reservoir containing perfusion fluid to which various concentrations of PBN (0, 5, 10, 30, 100, and 1,000 /LLM/L) had been added. Any resulting changes in heart rate, coronary flow, and the electrocardiogram were noted. Regional ischemia was then induced for various periods of time, followed by 3 minutes reperfusion using the same PBN-containing solution. During both periods coronary flow, heart rate, and the electrocardiogram were recorded.
PROTOCOL FOR LATE ADMINISTRATION OF PBN. In these studies, hearts (n = 12 in each group) were subjected to 10 minutes control aerobic perfusion, 10 minutes regional ischemia, and 3 minutes reperfusion. In control hearts, standard perfusion fluid was used throughout, whereas in the late administration group, a second perfusion fluid reservoir containing PBN (30 fiM/L) was attached to a side arm of the aortic cannula, and the inflow line was switched to deliver this solution 2 minutes before the onset of reperfusion and throughout the reperfusion period.
PROTOCOL FOR ISCHEMIC TIME VS. REPERFUSION VUL-NERABILITY STUDIES. In the studies, hearts (n = 12 in each group) were initially subjected to two consecutive 5-minute periods of aerobic perfusion. This was followed by coronary artery ligation and the induction of regional ischemia for various periods (5, 10, 20, 30, or 40 minutes) followed by reperfusion for 3 minutes. In some studies (early administration), PBN (30 FXM/L) was added to the perfusate 5 minutes prior to the induction of ischemia. In the other experiments (late administration), the PBN was added 2 minutes prior to reperfusion. In both sets of experiments, PBN-containing perfusion fluid was used throughout the reperfusion period. The results were compared to those from hearts that had been PBN-free throughout the experiment.
Indices of Function and Measurement of Rhythm Disturbances
An epicardial electrocardiogram was recorded throughout the experiment. This was obtained using two silver electrodes attached directly to the heart. The electrocardiograms were analysed for the incidence and duration of ventricular fibrillation that was classified as "reversible" (spontaneously reverting to regular rhythm) or "irreversible" (persisting throughout the study), and the duration of the reperfusion period over which the heart remained in normal sinus rhythm. Heart rate was derived from the electrocardiogram, and coronary flow was measured by collecting the coronary effluent as it flowed from the heart.
Tests of Statistical Significance
The duration of ventricular fibrillation and the time spent in normal sinus rhythm were expressed as the mean ± SEM. A one-way analysis of variance was first carried out; if treatment was a source of variance, then each of the PBN treated groups was compared with the control group using the unpaired t test. An analogous procedure was followed for comparing binomially distributed variables such as the incidence of ventricular fibrillation. An overall %squared test for a 2 x n table was constructed, followed by a sequence of 2 x 2 x-squared tests using the Yates correction to compare individual groups.
Results

PBN Dose-Response Studies (Early Administration)
SELECTION OF ISCHEMIC DURATION. Manning and Hearse 2 have previously reported that in the rat and several other species, the vulnerability to reperfusioninduced arrhythmias is determined by the duration of preceding ischemia and that a complex bell-shaped time-response relation exists. In the present studies, the control group was required to exhibit a high incidence of reperfusion-induced ventricular fibrillation to permit the assessment of the antiarrhythmic effects of PBN with the minimum group size. Therefore, preliminary studies were performed in which hearts (n = 12 in each group) were subjected to 5, 10, 20, 30, or 40 minutes of regional ischemia followed by reperfusion. The results ( Figure 1 ) revealed that 17, 100, 67, 41, and 33% of hearts, respectively, fibrillated (reversible plus irreversible fibrillation). An optimum was apparent with 10 minutes ischemia where 100% of hearts fibrillated on reperfusion, 83% of which were in irreversible fibrillation. For the following studies 10 minutes ischemia was selected.
PBN AND REPERFUSION-INDUCED ARRHYTHMIAS: DOSE-RESPONSE STUDIES. Hearts (n = 12 in each group) were subject to 10 minutes ischemia and reperfusion in the presence of various concentrations of PBN (0, 5, 10, 30, 100, or 1,000 /AM/L). The results ( Figure 2 and Table 1 ) demonstrated that PBN afforded a dose-dependent antiarrhythmic effect that reduced irreversible ventricular fibrillation from its control value of 83% to 50% (p = NS), 25% (p = <0.05), 17% (p = <0.01), 17% (p = <0.01), and 41% (p = <0.05) at concentrations of 5, 10, 30, 100, and 1,000 /o,M/L, respectively. The mean duration of ventricular fibrillation, when expressed as a mean of all hearts studied, fell from 138 ± 16 seconds in the control group to 30 ± 17 seconds (p = < 0.001) in the group of hearts perfused with PBN at a concentration of 30 fjM/L. However, this reduction was attributable, in part, to the reduction in the number of hearts fibrillating rather than to the duration of fibrillation in individual hearts. When expressed as mean duration of fibrillation in those hearts that fibrillated (n = 6), there was still a significant (p = <0.05) reduction in mean duration (to 60 ± 31 seconds).
EFFECTS OF PERFUSION CONDITIONS ON CORONARY FLOW
AND HEART RATE. The results in Figure 3 show the changes in coronary flow and heart rate during the periods of control perfusion, ischemia, and reperfusion in 5 groups of 12 hearts in contrast to 12 sham operated hearts (A in Figure 3 ; sutures placed into position but not tied). In the sham operated controls, there was a small, but progressive, decline in heart rate which, over the 23-minute experiment, fell by 7% from 338 ± 10 beats/min to 316 ±12 beats/min (p = NS). In the same group, coronary flow fell from 15.0 ±0.3 ml/min to 12.4 ±0.3 ml/min (p = <0.001). Coronary artery ligation resulted in a further fall in . Effect of perfusion conditions on coronary flow and heart rate. Hearts were subject to regional ischemia for 5 minutes (m); JO minutes (O); 20 minutes (a); 30 minutes (*); or 40 minutes (A). Each was followed by a 3-minute period of reperfusion and values were compared with those from hearts subject to sham occlusion (no ischemia) for 40 minutes (A). Coronary flow (top) and heart rate (bottom) were measured. Each point represents the mean of 12 hearts and the bars indicate the SEM. *p = <0.05, **p = <0.01, ***p = <0.001. Note that in the 10-minute group all hearts fibrillated on reperfusion, and, therefore, it was impossible to record a heart rate value.
heart rate which, after 5 minutes occlusion, had fallen from its corresponding sham operated control value of 323 ± 7 to 278 ± 13 beats/min {p = <0.001). This decline continued with longer durations of ischemia such that in the 10 minutes ischemia group the value for heart rate was 262 ± 13 beats/min, which compared to 319 ± 5 beats/min in the sham operated controls. As shown in the bottom panel of Figure 3 , similar declines in heart rate were observed after 20, 30, and 40 minutes of ischemia (to 265 ± 12, 253 ± 8, and 253 ±11 beats/min, respectively). Reperfusion resulted in a small but incomplete recovery of heart rate in the 5-, 20-, 30-, and 40-minute groups where the heart rates after 3 minutes reperfusion were 278 ±13, 280 ±11, 273 ±6, and 278 ± 8 beats/min, respectively. In the 10 minutes ischemia group, all hearts fibrillated on reperfusion, and therefore, it was impossible to record a heart rate value in this group.
As expected, total coronary flow fell by approximately half as a consequence of the induction of ischemia; the mean value after 5 minutes ischemia was 7.3 ± 0.3 ml/min, and after 10 minutes the value was 7.0 ±0.3 ml/min. On reperfusion after 10 minutes ischemia, mean coronary flow returned to 13.3 ± 0.4 ml/min, a value that did not differ significantly from its time-matched sham-operated control (12.4 ±0.3 ml/min). As shown in Figure 3 (top), similar decline and recovery profiles were seen for coronary flow with 5, 20, 30, and 40 minutes ischemia and reperfusion.
EFFECT OF PBN ON CORONARY FLOW AND HEART RATE. Table 2 shows the effect of various concentrations of PBN on heart rate and coronary flow expressed as a percent of their time-matched drug-free controls at various points in the experimental sequence. In essence, although there were some significant reductions in heart rate during the preischemic control period and also during the postischemic reperfusion period, these changes were relatively small. PBN reduced coronary flow by a small but significant extent at all concentrations during the period of preischemic control perfusion. Mean coronary flow in the drug-treated groups remained below their time- Table 1 ). Since all hearts in the control group fibrillated, the control value was taken from the sham operated value in Figure 3 . *p<0.05; tp<0.001; + /><0.01; mean ± SEM.
matched drug-free controls during both ischemia and reperfusion.
PBN Studies of Late Administration
To assess whether the protective effect of PBN against reperfusion-induced arrhythmias was direct, acting during the reperfusion period, or indirect, arising as a consequence of the effects of the drug on the heart during ischemia, hearts were studied with PBN (30 /AM/L) administered 2 minutes before reperfusion (after 10 minutes regional ischemia).
The results ( Figure 4 and Table 3 ) show that despite the late administration of the PBN, the drug was highly effective in that it reduced significantly (p = <0.05) the incidence of ventricular fibrillation (reversible plus irreversible) to 50% (6 of 12) from its control value of 100% (12 of 12). Similarly, the incidence of irreversible fibrillation was reduced significantly (p = <0.05) from its control value of 83% (10 of 12) to 41% (5 of 12) in the PBN group. This reduction was reflected in a striking increase in the mean percent time that the hearts were in normal sinus rhythm during reperfusion (43 ± 14%; 78 ± 26 seconds) in the PBN group compared with control (7 ± 8%; 12 ± 14 seconds, p = <0.05). It is clear that there was no significant difference between these results and those with PBN administration prior to ischemia. This provides evidence that PBN exerts its antifibrillatory effect directly during the reperfusion period.
Effect of PBN on Ischemic Time vs. Reperfusion Vulnerability Profile
In this series of experiments, the object was to ascertain whether PBN causes an absolute reduction in the vulnerability to reperfusion-induced arrhythmias irrespective of the duration of preceding ischemia or whether it only has a delaying effect, which shifts the time-response curve to the right. EARLY PBN ADMINISTRATION. Hearts (n = 12 in each group), perfused with standard perfusion fluid were subjected to 5, 10, 20, 30, or 40 minutes ischemia followed by reperfusion for 3 minutes. In one series of studies, PBN (30 fiMJL) was included in the perfusion fluid 5 minutes before the onset of ischemia and was then maintained in the perfusion fluid for the rest of the experiment. The results were compared with those in which PBN was omitted throughout the experiment (Figure 1 ). The results (Figure 1 and Figure 5 , top) show that in the absence of PBN a bell-shaped curve was obtained for the relationship between the incidence of reperfusion-induced ventricular fibrillation and the duration of the preceding period of ischemia. Thus, after 5 minutes ischemia only 17% (2 of 12) of the hearts exhibited reperfusion-induced ventricular fibrillation (total) and only 8% (1 of 12) exhibited irreversible fibrillation. Increasing the ischemic duration to 10 minutes resulted in a large increase in reperfusioninduced ventricular fibrillation, increasing the values to 100% (12 of 12) and 83% (10 of 12) for total and irreversible fibrillation, respectively. Ten minutes ischemia appeared to result in maximal vulnerability since beyond this time there was a progressive decline in the incidence of reperfusion-induced ventricular fibrillation. The incidences of reversible plus irreversible reperfusion-induced fibrillation were 67, 41, and 33% after 20, 30, and 40 minutes ischemia and the corresponding incidences of irreversible fibrillation were 58, 25, and 8%.
In hearts perfused with PBN ( Figure 5, bottom) , a bell-shaped curve was also apparent. However, the curve was shifted to the right and downwards. The maximal vulnerability to ventricular fibrillation occurred after 30 minutes ischemia. Thus, after 5, 10, 20, 30, and 40 minutes ischemia the incidences of reversible plus irreversible fibrillation were 8, 50, 50, 100, and 50%, respectively, and the values for irreversible fibrillation were 8, 17, 41, 67, and 33%, respectively.
A similar pattern of displacement of the curve to the left, plus a tendency to reduce the height of the curve, was also apparent for the results of the mean duration of ventricular fibrillation shown in Figure 6 and Table 2 . LATE PBN ADMINISTRATION. Since it was found that PBN was as effective when it was given just prior to reperfusion as it was when present throughout ischemia and reperfusion (Figure 4, Table 3 ), the shift in the ischemic time vs. reperfusion vulnerability curve demonstrated in the previous section ( Figure 5 ) would be expected to occur under conditions of late administra-tion. This was investigated in studies in which hearts (n= 12 in each group) were subjected to regional ischemia for 5, 10, 20, 30, or 40 minutes in the absence or presence of PBN (30 /iM/L), administered 2 minutes prior to reperfusion. The results (Figure 7 , Table 3 ) show that in controls a bell-shaped doseresponse curve was obtained, and, as in the early administration studies (Figure 5 ), the inclusion of PBN resulted in a marked shift of the curve to the right. Also, as with early administration, there was a tendency for the height of the curve to be reduced. Thus, at the time of peak vulnerability (following 10 minutes ischemia) in the PBN-free control series the incidences of total ventricular fibrillation and irreversible fibrillation were 100% and 83%, respectively, whereas the corresponding values were 50% (p = <0.05) and41% (p = <0.05) for the PBN treated group at its time of peak vulnerability (following 20 minutes ischemia). The relation between the duration of ventricular fibrillation and the duration of preceding ischemia ( Figure  6 , Table 3 ) was also shifted to the right and down. Thus, after an ischemic duration of 10 minutes, the . The effect of PBN on the relation between the duration of ischemia and the incidence of reperfusion-induced ventricular fibrillation (early administration study). Hearts (n = 12 in each group) were subjected to 5, 10, 20, 30, 
100-
or 40 minutes ischemia followed by 3 minutes reperfusion. The incidence (%) of reperfusion-induced ventricular fibrillation was expressed as irreversible fibrillation (open bars) and as ventricular fibrillation (reversible plus irreversible, indicated by the solid boxes).
In one series (top), PBN was not used, but in the second series (bottom), PBN (30 yMIl) was present in the perfusion fluid 5 minutes before the onset of ischemia and throughout the remainder of the experiment. *p = <0.05, **p = <0.01 when compared to the corresponding time in the control group. Hearts were subjected to 5, 10, 20, 30, or 40 minutes ischemia followed by 3 minutes reperfusion. The mean total duration of ventricular fibrillation was recorded for PBN free control hearts (•);• hearts in which PBN (30 fx.Mll) was present 5 minutes prior to ischemia and throughout the remainder of the experiment (•); and hearts in which PBN (30 JJLMII) was present 2 minutes prior to reperfusion and throughout the remainder of the experiment (O). Each point is the mean of 12 hearts and the bars represent the SEM. Statistical comparisons have been made atfixed time points; *p = <0.05; ***p = <0.001. mean duration of reperfusion-induced ventricular fibrillation was 138 ± 16 seconds in the PBN-free control group, 30 ± 17 seconds in the early PBN administration group (p = <0.001), and 70 ± 24 seconds in the late PBN administration group (p = <0.05).
Discussion
The results of the present study demonstrate that PBN, the organic agent designed specifically to trap free radicals for electron spin resonance studies, can dramatically reduce the vulnerability of the rat heart to reperfusion-induced arrhythmias following a brief (10minute) period of regional ischemia. Thus, at its optimal concentration of 30 ^iM/L, this agent reduced fibrillation (reversible plus irreversible) to 50% from its control incidence of 100%. PBN exerted this protective effect in a dose-dependent manner and without any major effects on heart rate or coronary flow. Although limited by their observation in the isolated rat heart, these results provide further support for the hypothesis that free radicals may play a role in the genesis of early reperfusion-induced arrhythmias and that inhibition or scavenging of these highly cytotoxic intermediates may provide an effective means of controlling these potentially lethal arrhythmias.
The major finding to emerge from the present studies is that although PBN reduced arrhythmias during reperfusion after 10 minutes ischemia (the optimal vulnerability time in control experiments), this was achieved by a delaying mechanism whereby the drug shifted the ischemic time vs. reperfusion-vulnerability curve to the right by 10 or 15 minutes. Thus, as shown in Figure 5 , in the presence of PBN (early administra-tion) the rat heart was still highly vulnerable to reperfusion-induced arrhythmias, but the ischemic time required for this vulnerability to be manifest was much longer than in control hearts. The consequence of this temporal shift was that after longer durations of ischemia, e.g., 30 minutes, the PBN treated hearts were more vulnerable than the control hearts. This observation of a delay in vulnerability would normally be attributed to some indirect drug-induced effects operative during the ischemic period. However, as shown in Figure 4 and Figure 7 the late administration of PBN still resulted in a reduction in the incidence of reperfusion-induced ventricular fibrillation after 10 minutes ischemia. Late administration of PBN also resulted in a tendency to shift the time vulnerability curve to the right (Figure 7) ; however, this shift was not as striking as in the early administration studies. Thus, although it might be argued that in the late administration studies PBN exerted some effect during the 1-minute period before reperfusion, it seems far more likely that it exerts a direct effect during the reperfusion phase. Therefore, it seems a more or less inescapable conclu- sion that although the duration of ischemia is ^primary determinant of the vulnerability of the heart to reperfusion-induced arrhythmias, PBN somehow alters this preconditioned state during the subsequent reperfusion phase. In this connection, it is now of considerable interest to ascertain whether other anti-free-radical interventions, such as allopurinol 14 and superoxide dismutase, 16 achieve a true antiarrhythmic effect or whether they, too, interfere with the relation between the duration of ischemia and the vulnerability to reperfusion-induced arrhythmias.
The present study provides some information concerning the identity of the free radicals that may be involved in the genesis of reperfusion arrhythmias. On the basis of our previous studies with allopurinol, which inhibits xanthine oxidase, the superoxide radical producing enzyme, 14 and studies with superoxide dismutase and catalase, which prevent the formation of hydroxyl radicals, it is tempting to propose that oxygen-derived free radicals may be involved. However, before drawing such a conclusion, a number of points should be considered. First, in relation to the kinetics of spin trapping, the reaction between superoxide and PBN is slow (compared with the corresponding rate for the hydroxyl radical). Since good antiarrhythmic activity at a PBN concentration of 30 fxM (a low concentration compared with that used normally in spin trapping experiments) was observed, the radical that reacts with the spin trap must be highly reactive. If oxygenderived radicals are involved, this would make the hydroxyl radical a far more likely candidate than the superoxide radical. Second, even if the hydroxyl radical were involved, the efficiency of trapping with 30 fiM PBN would be expected to be very low due to the high rate constants of the hydroxyl radical with neighboring biomolecules that are at much higher concentrations. It has, therefore, been speculated (T. Slater, personal communication) that PBN might be acting as a chain-breaking antioxidant that would interrupt complex free radical chain reactions initiated by the hydroxyl radical at the onset of reperfusion. The secondary radicals so formed would be of lower chemical reactivity than the hydroxyl radical. The third point to consider is that at the present time we cannot exclude the possibility that other free radicals (e.g., carbon centered) may be involved or even that PBN may be acting via a non-free-radical-mediated mechanism, possibly by binding to some membrane protein, enzyme, or channel.
With regard to the mechanism by which free radicals may precipitate arrhythmias (and other aspects of ischemic injury), it is well known 22 that free radicals can cause severe membrane injury by initiating a variety of reactions, including lipid peroxidation, which may alter membrane integrity and permeability characteristics. It is also well established that free radicals can cause the functional impairment of a number of membrane channels and ionic pump mechanisms. 2627 Induction of such injury as a consequence of a "burst" of free radical production at the onset of reperfusion may result in catastrophic perturbations of ionic bal-ance. This, together with the heterogeneity of injury and recovery 2 that characterizes early reperfusion, may create an ideal scenario for the establishment of reentry circuits and consequent precipitation of ventricular fibrillation. However, before attributing such mechanisms to the genesis of reperfusion-induced arrhythmias, there is a clear need for more direct proof of a free radical involvement. This would involve using techniques such as electron spin resonance and subcellular membrane characterization where one would have to demonstrate the production of the free radicals at the appropriate time and show that under the conditions of the present study the spin trap agent is acting as a highly effective free radical scavenger and that, as a consequence, membrane injury that occurred in the absence of the agent is prevented by its presence.
As discussed earlier, a number of triggers, in addition to free radicals, have been suggested to be responsible for the genesis of reperfusion-induced arrhythmias. These include stimulation of the a and /3 receptors, the elevation of tissue cAMP content, the release of lysophosphatides, and disturbances of potassium, sodium, and calcium conductance. It may well be the case that one or more of these factors are potentially capable of triggering reperfusion-induced arrhythmias, but that under normal circumstances, free radicals may be the most common trigger. If this were the case then it would not be unreasonable to expect these triggers to be associated with different ischemic time-reperfusion vulnerability profiles. Thus, lysophosphatides, for example, might require a longer period of ischemia before they become a significant factor in arrhythmogenesis. To investigate such a possibility it would be necessary to compare the relative susceptibility of arrhythmias generated by reperfusion after different ischemic periods to different types of antiarrhythmic intervention. Such studies are currently underway in our laboratories.
